Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (11280)	11/5/2018 4:34:39 PM
From: drkaz	1 Recommendation Recommended By HardToFind Read Replies (2) \| Respond to of 12873

Yeah - I remember reading something recently about an association between HSV-1 infection and Alzheimer's disease. sciencedaily.com And the actual review article, & not just the Science Daily summary of it. It's actually not too dense or overjammed with scientific lingo for a review article. frontiersin.org An anti-herpes drug that can destroy the virus, and that has extremely low toxicity could be an effective preventative or at least treatment - if they can figure out a way to deliver it through the blood-brain barrier. It's all more "pie-in-the-sky" though unless the company can actually deliver a drug,... period,... for clinical testing. And we all know how that track record looks to date.